PCRFF(PCRFF)
PCRFF
No analyst ratings available
No analyst price targets available for PCRFF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $7.79T | $8.27T | $8.80T | $9.18T | $9.60T |
| Low | $7.43T | $7.76T | $8.33T | $8.69T | $9.08T |
| High | $8.52T | $8.98T | $9.59T | $10.01T | $10.46T |
| EBITDA Avg | $1.15T | $1.22T | $1.30T | $1.36T | $1.42T |
| Low | $1.10T | $1.15T | $1.23T | $1.28T | $1.34T |
| High | $1.26T | $1.33T | $1.42T | $1.48T | $1.55T |
| EBIT Avg | $612.96B | $650.62B | $692.85B | $722.86B | $755.25B |
| Low | $585.12B | $610.51B | $655.59B | $683.99B | $714.64B |
| High | $670.18B | $706.59B | $754.91B | $787.61B | $822.90B |
| Net Income Avg | $461.59B | $562.41B | $668.75B | $738.60B | $822.99B |
| Low | $429.33B | $523.09B | $622.00B | $686.97B | $765.46B |
| High | $515.35B | $627.90B | $746.63B | $824.61B | $918.83B |
| EPS Avg | $197.68 | $240.85 | $286.39 | $316.30 | $352.44 |
| Low | $183.86 | $224.01 | $266.37 | $294.19 | $327.81 |
| High | $220.70 | $268.90 | $319.74 | $353.14 | $393.49 |
| Analysts (Rev / EPS) | 15 / 1 | 15 / 1 | 11 / 1 | 7 / 1 | 6 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $1.92T | $2.01T | $2.15T |
| Low | $1.87T | $1.95T | $2.09T |
| High | $2.03T | $2.13T | $2.28T |
| EBITDA Avg | $283.92B | $296.92B | $317.70B |
| Low | $276.13B | $288.78B | $308.99B |
| High | $300.78B | $314.56B | $336.57B |
| EBIT Avg | $151.13B | $158.05B | $169.11B |
| Low | $146.99B | $153.72B | $164.48B |
| High | $160.11B | $167.44B | $179.16B |
| Net Income Avg | $122.97B | $132.01B | $109.81B |
| Low | $118.59B | $127.31B | $105.90B |
| High | $132.47B | $142.21B | $118.29B |
| EPS Avg | $52.66 | $56.53 | $47.02 |
| Low | $50.78 | $54.52 | $45.35 |
| High | $56.73 | $60.90 | $50.65 |
| Analysts (Rev / EPS) | 6 / 1 | 5 / 1 | 3 / 1 |